Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07516509 · ClinicalTrials.gov registry record
Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance
A clinical trial, sponsored by AdventHealth Translational Research Institute.
- Not yet
- Registry status
- 36
- Enrollment target
NCT07516509: Clinical Trial study, sponsored by AdventHealth Translational Research Institute.
NCT07516509 is a clinical trial that has not yet begun recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07516509 has not yet begun recruiting, sponsored by AdventHealth Translational Research Institute.
- NOT YET RECRUITING
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to find new signs or signals in muscle cells that can help us understand when the body isn't responding well to insulin (a condition called insulin resistance).
Primary Outcome
Skeletal muscle insulin sensitivity will be quantified with the HE clamp and compared between groups.
Interventions
- OTHER DEXA
- OTHER VO2 Max
- OTHER Peripheral Microvascular Reactivity
- OTHER Skeletal Muscle Insulin Sensitivity
- OTHER Non-Oxidative Glucose Disposal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-12 |
What is known before NCT07516509 opens enrollment
NCT07516509 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which DEXA is the first listed.
NCT07516509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07516509 about?
NCT07516509 is a clinical study titled "Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance". The purpose of this study is to find new signs or signals in muscle cells that can help us understand when the body isn't responding well to insulin (a condition called insulin resistance).
What is the current status of trial NCT07516509?
This trial is currently not yet recruiting. The enrollment target is 36 participants. The study started on 2026-06. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07516509?
The interventions under investigation include: DEXA (OTHER), VO2 Max (OTHER), Peripheral Microvascular Reactivity (OTHER), Skeletal Muscle Insulin Sensitivity (OTHER), Non-Oxidative Glucose Disposal (OTHER).
Who is sponsoring clinical trial NCT07516509?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia